Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age

Prenatal Diagnosis

Volumn 30, Issue 3, 2010, Pages 198-206

  Nakata, Naomi ^a   Wang, Yuemei ^a   Bhatt, Sucheta ^a  

^a GENZYME GENETICS   (United States)

Author keywords

Genetic counseling; Prenatal diagnosis; Prenatal serum screening; Testing uptake

Indexed keywords

ADULT; AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; DIAGNOSTIC TEST; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL DECISION MAKING; PRENATAL SCREENING; PRIORITY JOURNAL;

ADULT; AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; DOWN SYNDROME; FEMALE; GENETIC COUNSELING; HUMANS; MATERNAL AGE; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK;

EID: 77349102207     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2434     Document Type: Article

References (20)

1. American College of Medical Genetics Practice Guideline. 2004. Second trimester maternal serum screening for fetal open neural tube defects and anueploidy. Genet Med 6: 540-541.
2. American College of Obstetricians and Gynecologists Practice Bulletin. 2001. Prenatal Diagnosis of Fetal Chromosomal Abnormalities. ACOG Pract Bull 27. ACOG: Washington, D.C.; 2001.
3. American College of Obstetricians and Gynecologists Practice Bulletin. 2007a. Screening for fetal chromosomal abnormalities. ACOG Pract Bull 77. Obstet Gynecol 109: 217-227.
4. American College of Obstetricians and Gynecologists Practice Bulletin. 2007b. Invasive prenatal testing for aneuploidy. ACOG Pract Bull 88. Obstet Gynecol 110: 1459-1467.
5. Baker D, Teklehaimanot S, Hassan R, Guze C. 2004. A look at a Hispanic and African American population in an urban prenatal diagnostic center: referral reasons, amniocentesis acceptance, and abnormalities detected. Genet Med 6: 211-218.
6. Benn PA, Egan JFX, Fan M, Smith-Bindman R. 2004. Changes in the utilization of prenatal diagnosis. Obstet Gynecol 103: 1255-1260.
7. Benn PA, Fan M, Egan JFX. 2005. Trends in the use of second trimester maternal serum screening from 1991 to 2003. Genet Med 7: 328-331.
8. Caughey AB, Hopkins LM, Norton ME. 2006. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 108: 612-616.
9. Chasen ST, McCullough LB, Chervenak FA. 2004. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population? Am J Obstet Gynecol 190: 769-774.
10. Chen J, Heffley D, Beazoglou T, Benn PA. 2003. Utilization of amniocentesis by women screening positive for Down syndrome on the second-trimester triple test. Community Genet 3: 24-30.
11. Eddleman KA, Malone FD, Sullivan L, et al. 2006. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 108: 1067-1072.
12. Hook EB. 1981. Down syndrome: frequency in human populations and factors pertinent to variation in rates. In Trisomy 21 (Down syndrome): Research Perspectives, de la Cruz FF, Gerald PS (eds). University Park Press: Baltimore; 3-18.
13. Malone FD, Canick JA, Ball RH, et al. 2005. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353: 2001-2011.
14. Spencer K, Aitken D, 2004. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies. Ultrasound Obstet Gynecol 24: 735-739.
15. Vergani P, Locatelli A, Biffi A, et al. 2002. Factors affecting the decision regarding amniocentesis in women at genetic risk because of age 35 years or older. Prenat Diagn 22: 769-774.
16. Wald NJ, Rodeck C, Hackshaw AK, et al. 2003. First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J Med Screen 10: 56-104.
17. Wapner R, Thom E., Simpson JL, et al. 2003. First-trimester screening for trisomies 21 and 18. N Engl J Med 349: 1405-1413.
18. Werner EF, Pastore LM, Karns LB, et al. 2008. Patient preferences for screening in the first trimester. Prenat Diagn 28: 1251-1255.
19. Wray AM, Ghidini A, Alvis C, et al. 2005. The impact of firsttrimester screening on AMA patients' uptake of invasive testing. Prenat Diagn 25: 350-353.
20. Zoppi MA, Ibba RM, Putzolu M, et al. 2001. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older. Obstet Gynecol 97: 916-920.